RYI-018: A Monoclonal Antibody Cannabinoid Receptor 1 Inverse Agonist For The Treatment of Metabolic Diseases

被引：0
|
作者：
Kretz-Rommel, Anke [1 ]
Ferrini, Roger [1 ]
Mann, Derek [2 ]
Shi, Lei [3 ]
Yang, Teddy [3 ]
Glicklich, Alan [1 ]
Grayson, Paul [1 ]
机构：
[1] Bird Rock Bio Inc, La Jolla, CA USA
[2] Newcaste Univ, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England
[3] RuiYi, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1153
引用
下载
收藏
页码：581A / 581A
页数：1
相关论文
共 50 条
  • [31] DISCOVERY OF NEW MOLECULE; AGONIST OF GPBAR1 AND INVERSE AGONIST OF RORGT, FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
    Biagioli, Michele
    Di Giorgio, Cristina
    Roselli, Rosalinda
    Bellini, Rachele
    Bordoni, Martina
    Marchiano, Silvia
    Massa, Carmen
    Urbani, Ginevra
    Distrutti, Eleonora
    Zampella, Angela
    Fiorucci, Stefano
    GASTROENTEROLOGY, 2023, 164 (06) : S416 - S416
  • [32] A Peripherally Selective CB1 Receptor Inverse Agonist Improves Metabolic Syndrome in Mice
    Khan, Nayaab S.
    Amato, George
    Vasukuttan, Vineetha
    Wang, Shaobin
    Snyder, Rodney
    Rosa, Taylor
    Wiethe, Robert
    Hackney, Aliah
    Runyon, Scott
    Maitra, Rangan
    FASEB JOURNAL, 2019, 33
  • [33] Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases
    Biagioli, Michele
    Di Giorgio, Cristina
    Morretta, Elva
    Bellini, Rachele
    Massa, Carmen
    Urbani, Ginevra
    Bordoni, Martina
    Marchiano, Silvia
    Lachi, Ginevra
    Sepe, Valentina
    Monti, Maria Chiara
    Distrutti, Eleonora
    Zampella, Angela
    Fiorucci, Stefano
    PHARMACOLOGICAL RESEARCH, 2024, 208
  • [34] Treatment of Metabolic Disorders with CB-1 Receptor inverse Agonists
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 874 - 875
  • [35] Inverse agonist effects of the cannabinoid CB1 receptor antagonist SR141716A in rat brain.
    Sim-Selley, LJ
    Brunk, LK
    Selley, DE
    FASEB JOURNAL, 2000, 14 (08): : A1447 - A1447
  • [36] Attenuation of food intake in chicks by an inverse agonist of cannabinoid receptor 1 administered by either injection or ingestion in hydrocolloid carriers
    Novoseletsky, Nataly
    Nussinovitch, Amos
    Friedman-Einat, Miriam
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2011, 170 (03) : 522 - 527
  • [37] Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents
    Shearman, Lauren P.
    Stribling, D. Sloan
    Camacho, Ramon E.
    Rosko, Kimberly M.
    Wang, Junying
    Tong, Sharon
    Feng, Yue
    Marsh, Donald J.
    Yu, Hong
    Guan, Xiaoming
    Spann, Stephanie K.
    MacNeil, Douglas J.
    Fong, Tung M.
    Metzger, Joseph M.
    Goulet, Mark T.
    Hagmann, William K.
    Plummer, Christopher W.
    Finke, Paul E.
    Mills, Sander G.
    Shah, Shrenik K.
    Truong, Quang
    Van der Ploeg, L. H. T.
    Maclntyre, D. Euan
    Strack, Alison M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 579 (1-3) : 215 - 224
  • [38] INV-101, a cannabinoid receptor-1 inverse agonist, reduces fibrosis in a bleomycin mouse model of IPF
    Crater, G. D.
    Gaucher, G.
    Harvey, M.
    Ravenelle, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [39] Influence of taranabant, a novel cannabinoid-1 receptor (CB-1R) inverse agonist, on ethinyl estradiol and norelgestromin pharmacokinetics
    Schwartz, Jules I.
    Yuan, Jinyu
    Li, Susie
    Miller, Deborah L.
    Rosko, Kim
    Zakson, Michelle
    Lasseter, Kenneth C.
    Wagner, John A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1192 - 1192
  • [40] A Monoclonal Antibody with Thyrotropin (TSH) Receptor Inverse Agonist and TSH Antagonist Activities Binds to the Receptor Hinge Region as Well as to the Leucine-Rich Domain
    Chen, Chun-Rong
    McLachlan, Sandra M.
    Rapoport, Basil
    ENDOCRINOLOGY, 2009, 150 (07) : 3401 - 3408
12345